World Mental Health Day - MHTN
Tag:

FDA

FDA Recall: An Antidepressant Has Been Upgraded to 2nd Highest Risk Level for Medication

Duloxetine Delayed-Release Capsules The FDA has issued a Class II recall for thousands of bottles of Duloxetine Delayed-Release Capsules, an antidepressant used to treat depression,...

FDA Panel Rejects MDMA-Based PTSD Treatment

In a setback for the emerging field of psychedelic therapies, a U.S. Food and Drug Administration advisory panel voted against approving an MDMA-based treatment...